| Detected | Trial | Change |
|---|---|---|
| 2026-05-30 | NCT02693535 TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a… |
Trial sites expanded: 174 -> 181 locations |
| 2026-05-16 | NCT01552434 Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in… |
Trial terminated |
| 2026-05-16 | NCT01552434 Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in… |
date change Primary completion moved earlier: 2026-10-31 -> 2026-05-08 |
| 2026-05-16 | NCT01552434 Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in… |
date change Completion moved earlier: 2026-10-31 -> 2026-05-08 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT00980460 | Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer | PRETEXT I Hepatoblastoma | Active, Not Recruiting |
| NCT02567435 | Combination Chemotherapy With or Without Temsirolimus in Treating Patients With… | Alveolar Rhabdomyosarcoma | Active, Not Recruiting |
| Phase 2 | |||
| NCT03297606 | Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR) | Lymphoma, Non-Hodgkin | Recruiting |
| NCT02693535 | TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a… | Lymphoma, Non-Hodgkin | Recruiting |
| NCT01946529 | Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small… | Desmoplastic Small Round Cell Tumor | Active, Not Recruiting |
| NCT01396408 | A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours | Advanced Rare Tumours | Active, Not Recruiting |
| NCT00977574 | Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or… | Endometrial Adenocarcinoma | Active, Not Recruiting |
| Phase 1 | |||
| NCT01087554 | Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced Cancer | Advanced Cancer | Active, Not Recruiting |
| NCT03203525 | Combination Chemotherapy and Bevacizumab With the NovoTTF-100L(P) System in Treating… | Advanced Malignant Neoplasm | Active, Not Recruiting |
| NCT02389309 | Dasatinib, Temsirolimus, and Cyclophosphamide in Treating Patients With Advanced… | Advanced Malignant Solid Neoplasm | Active, Not Recruiting |
| NCT01375829 | Ixabepilone and Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic… | Adult Solid Neoplasm | Active, Not Recruiting |
| NCT01187199 | Phase I Trial of Bevacizumab and Temsirolimus in Combination With 1) Carboplatin, 2)… | Advanced Cancer | Active, Not Recruiting |
| Not specified | |||
| NCT04199026 | Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients… | Metastatic Sarcoma | Recruiting |